Drugs News and Research

RSS

Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases

A new study by researchers at Karolinska Institutet supports the theory that replacement of dysfunctional immune cells in the brain has therapeutic potential for neurodegenerative diseases like ALS and Alzheimer's disease.

19 Nov 2018

Adolescents increasingly choose marijuana over cigarettes, alcohol

The "gateway pattern" of adolescent substance use is changing, and marijuana is increasingly the first substance in the sequence of adolescent drug use, according researchers at the Columbia University Mailman School of Public Health.

19 Nov 2018

Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease

One in five people with Alzheimer's disease who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland.

19 Nov 2018

Researchers identify gene vital for post-stroke recovery

Having certain specific variants of the PATJ gene predisposes to worse recovery from ischemic stroke. 7 out of 10 patients with these variants suffer severe sequelae three months after having a stroke, in other words, they are in a situation of dependence, compared to less than half of patients who do not present these variants.

19 Nov 2018

Receptor structure could be key to developing new osteoporosis drugs

Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones. The receptor is now one of the main candidates for developing new drugs to treat osteoporosis.

19 Nov 2018

Cardiff University collaborates with Takeda to identify new treatment approaches for psychiatric disorders

Cardiff University has formed a drug discovery collaboration with Takeda to identify new approaches for treating schizophrenia and other psychiatric disorders.

From Takeda 19 Nov 2018

Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising

The scene is shadowy, and the background music foreboding. On the TV screen, a stream of beleaguered humans stand in an unending line.

19 Nov 2018

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Patients who have persistently high levels of inflammation following percutaneous coronary intervention for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of 7,026 patients published in the European Heart Journal.

19 Nov 2018

Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors

Meningiomas, a type of brain tumor, are usually easy to treat. However, there are a few subtypes that follow a very aggressive course and have high recurrence rates, i.e. there is a high risk of them coming back after treatment.

19 Nov 2018

Researchers develop novel mouse model to study immunomodulatory therapies

Because mice do not respond to immunomodulatory drugs, preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice.

19 Nov 2018

Novel approach could provide painless, efficient alternative for treating eye diseases

Nanyang Technological University, Singapore scientists have developed a 'contact lens' patch with microneedles that could provide a painless and efficient alternative to current methods of treating eye diseases such as glaucoma and macular degeneration.

19 Nov 2018

Individuals identified as lesbian, gay more likely to misuse opioids than heterosexual

Men and women who identify as lesbian, gay, or bisexual are more likely to misuse opioids when compared with those who identify as heterosexual, a new study shows.

19 Nov 2018

Urine test to check if patients take their medications will save the NHS money, say researchers

A research team led by scientists and doctors in Leicester and the Netherlands has shown that a urine test to measure whether patients are taking their medications will save the NHS money.

19 Nov 2018

Surprising discovery about BH4 may rekindle interest in once-promising pathway

In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, PhD, and chemist Kai Johnsson, PhD, his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief.

19 Nov 2018

Human drugs alter cricket personality

Crickets that are exposed to human drugs that alter serotonin levels in the brain are less active and less aggressive than crickets that have had no drug exposure, according to a new study led by researchers from Linköping University. The findings have been published in Scientific Reports.

18 Nov 2018

Scientists discover new inhibitor that decreases lung inflammation

Scientists from the University of Sheffield have discovered a new inhibitor which decreases lung inflammation and could hold the key to treating Acute Respiratory Distress Syndrome - a life-threatening disease which affects thousands of people in the UK.

18 Nov 2018

New strategy to hinder emergence of antimicrobial-resistant pathogens

With many disease-causing bacteria ratcheting up their shields against current drugs, new tactics are vital to protect people from treatment-resistant infections.

17 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission

During a heart attack the supply of oxygen to heart cells is decreased. This reduced oxygen level, called hypoxia, causes the cell's powerhouses, the mitochondria, to fragment, impairing cell function and leading to heart failure. Until now, few details were known on how this important process occurs.

17 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

Drugs News and Research

Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases

Adolescents increasingly choose marijuana over cigarettes, alcohol

Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease

Researchers identify gene vital for post-stroke recovery

Receptor structure could be key to developing new osteoporosis drugs

Cardiff University collaborates with Takeda to identify new treatment approaches for psychiatric disorders

Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors

Researchers develop novel mouse model to study immunomodulatory therapies

Novel approach could provide painless, efficient alternative for treating eye diseases

Individuals identified as lesbian, gay more likely to misuse opioids than heterosexual

Urine test to check if patients take their medications will save the NHS money, say researchers

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Human drugs alter cricket personality

Scientists discover new inhibitor that decreases lung inflammation

New strategy to hinder emergence of antimicrobial-resistant pathogens

FDA approves antibacterial drug to treat travelers' diarrhea

Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission

New first-line treatment for peripheral T-cell lymphoma approved by FDA

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News